Our Prices
Quantity :   1-5 Strips   6-9 Strips   10-29 Strips   30-60 Strips   Price Per Strip :   $ 5.00 each    $ 4.50 each    $ 4.00 each    $ 3.50 each
Plus $7.50 for airmail to any country. There are no additional costs.
Quantity	1 Strip 2 Strips 3 Strips 4 Strips 5 Strips 6 Strips 7 Strips 8 Strips 9 Strips 10 Strips 11 Strips 12 Strips 13 Strips 14 Strips 15 Strips 16 Strips 17 Strips 18 Strips 19 Strips 20 Strips 21 Strips 22 Strips 23 Strips 24 Strips 25 Strips 26 Strips 27 Strips 28 Strips 29 Strips 30 Strips 31 Strips 32 Strips 33 Strips 34 Strips 35 Strips 36 Strips 37 Strips 38 Strips 39 Strips 40 Strips 41 Strips 42 Strips 43 Strips 44 Strips 45 Strips 46 Strips 47 Strips 48 Strips 49 Strips 50 Strips 51 Strips 52 Strips 53 Strips 54 Strips 55 Strips 56 Strips 57 Strips 58 Strips 59 Strips 60 Strips
Details Amantadine (Generic Symmetrel) Amantadine hydrochloride capsules are indicated for the prophylaxis and treatment of signs and symptoms of infection caused by various strains of influenza A virus. Amantadine hydrochloride capsules are also indicated in the treatment of parkinsonism and drug-induced extrapyramidal reactions. Influenza A Prophylaxis Amantadine hydrochloride capsules are indicated for chemoprophylaxis against signs and symptoms of influenza A virus infection when early vaccination is not feasible or when the vaccine is contraindicated or not available. In the prophylaxis of influenza, early vaccination on an annual basis as recommended by the Centers for Disease Control's Immunization Practices Advisory Committee is the method of choice. Because amantadine does not completely prevent the host immune response to influenza A infection, individuals who take this drug may still develop immune responses to natural disease or vaccination and may be protected when later exposed to antigenically related viruses. Following vaccination during an influenza A outbreak, amantadine prophylaxis should be considered for the 2 to 4 week time period required to develop an antibody response. Influenza A Treatment Amantadine hydrochloride capsules are also indicated in the treatment of uncomplicated respiratory tract illness caused by influenza A virus strains especially when administered early in the course of illness. There are no well-controlled clinical studies demonstrating that treatment with amantadine hydrochloride will avoid the development of influenza A virus pneumonitis or other complications in high risk patients. There is no clinical evidence indicating that amantadine is effective in the prophylaxis or treatment of viral respiratory tract illnesses other than those caused by influenza A virus strains. Parkinson's Disease/Syndrome Amantadine is indicated in the treatment of idiopathic Parkinson's disease (Paralysis Agitans), postencephalitic parkinsonism and symptomatic parkinsonism which may follow injury to the nervous system by carbon monoxide intoxication. It is indicated in those elderly patients believed to develop parkinsonism in association with cerebral arteriosclerosis. In the treatment of Parkinson's disease, amantadine is less effective than levodopa, (-)-3-(3,4-dihydroxyphenyl) L-alanine, and its efficacy in comparison with the anticholinergic antiparkinson drugs has not yet been established. Drug-induced Extrapyramidal Reactions Amantadine hydrochloride is indicated in the treatment of drug-induced extrapyramidal reactions. Although anticholinergic-type side effects have been noted with amantadine when used in patients with drug-induced extrapyramidal reactions, there is a lower incidence of these side effects than that observed with the anticholinergic antiparkinson drugs.